Finance

Beta
Lists
002020:SHE
Zhejiang Jingxin Pharmaceutical Co., Ltd
CNÂ¥12.19
-1.61%
(-0.20) 1D
Jun 16, 3:04:15 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002020...
Open
CNÂ¥12.34
High
CNÂ¥12.35
Low
CNÂ¥12.14
Mkt. cap
10.69B
Avg. vol.
10.17M
Volume
7.74M
Dividend
2.87%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jun 11, 2026
P/E ratio
13.18
52-wk high
CNÂ¥22.62
52-wk low
CNÂ¥12.09
EPS
CNÂ¥0.92
Shares outstanding
861.03M
No. of employees
4K
Open
CNÂ¥12.34
High
CNÂ¥12.35
Low
CNÂ¥12.14
Mkt. cap
10.69B
Avg. vol.
10.17M
Volume
7.74M
Dividend
2.87%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jun 11, 2026
P/E ratio
13.18
52-wk high
CNÂ¥22.62
52-wk low
CNÂ¥12.09
EPS
CNÂ¥0.92
Shares outstanding
861.03M
No. of employees
4K
News stories
From sources across the web
About Zhejiang Jingxin Pharmaceutical Co., Ltd
CEO-
Employees3.73K
Founded1990
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.06B
1.03B
1.02B
923.03M
Cost of goods sold
515.55M
506.52M
540.75M
451.52M
Cost of revenue
515.55M
506.52M
540.75M
451.52M
Research and development expenses
97.41M
89.68M
93.56M
83.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
201.13M
220.72M
200.08M
186.30M
Operating expense
309.73M
333.83M
292.95M
280.97M
Total operating expenses
825.28M
840.35M
833.70M
732.49M
Operating income
235.19M
191.30M
187.47M
190.55M
Other non operating income
-1.99M
-969.56K
1.49M
-14.07M
EBT including unusual items
257.05M
214.65M
199.41M
191.37M
EBT excluding unusual items
255.81M
206.53M
197.34M
189.61M
Income tax expense
30.22M
25.44M
14.16M
25.22M
Effective tax rate
11.76%
11.85%
7.10%
13.18%
Other operating expenses
7.19M
17.32M
5.19M
13.98M
Net income
224.59M
187.73M
182.37M
165.20M
Net profit margin
21.18%
18.20%
17.86%
17.90%
Earnings per share
-
-
-
-
Interest and investment income
22.92M
19.21M
18.40M
14.30M
Interest expense
-1.68M
-1.63M
-
-1.17M
Net interest expenses
21.23M
17.58M
18.40M
13.14M
Depreciation and amortization charges
-
-
-
-
EBITDA
312.27M
260.03M
254.25M
257.33M
Gain or loss from assets sale
256.69K
-256.69K
574.50K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more